Cipla Uganda unit to raise $45 M through IPO
17 August 2018 | News
Cipla Quality Chemical Industries, which is majority owned by India's third-largest drugmaker, is selling 657,179,319 shares, or an 18 percent stake in the company.
Image credit- chinadaily.com.cn
The Ugandan unit of Indian drugmaker Cipla priced its initial public offering (IPO) at 256.5 shillings per share, aiming to raise $45 million from its listing on the Kampala stock exchange next month.
Cipla Quality Chemical Industries, which is majority owned by India's third-largest drugmaker, is selling 657,179,319 shares, or an 18 percent stake in the company.
It makes a range of drugs including antiretrovirals, anti-malaria and Hepatitis B and C drugs, which it sells mostly in sub-Saharan African countries, and will become the 17th company to list on the Ugandan stock exchange.
Cipla has a manufacturing plant in Kampala and is set to make its market debut in September.
